Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ICG165 / iCell Gene Therap
NCT05445765: Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia	Not yet recruiting	1	10	RoW	anti-CD33 CAR T cells	iCell Gene Therapeutics, iCar Bio Therapeutics	Relapsed and/or Refractory Acute Myeloid Leukemia, High Risk Hematologic Malignancies	06/24	06/24